The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases
Abstract
The safety and antifungal efficacy of amphotericin B lipid complex (ABLC) were evaluated in 556 cases of invasive fungal infection treated through an open-label, single-patient, emergency-use study of patients who were refractory to or intolerant of conventional antifungal therapy. All 556 treatment episodes were evaluable for safety. During the course of ABLC therapy, serum creatinine levels significantly decreased from baseline (P < .02). Among 162 patients with serum creatinine values > or = 2.5 mg/dL at the start of ABLC therapy (baseline), the mean serum creatinine value decreased significantly from the first week through the sixth week (P < or = .0003). Among the 291 mycologically confirmed cases evaluable for therapeutic response, there was a complete or partial response to ABLC in 167 (57%), including 42% (55) of 130 cases of aspergillosis, 67% (28) of 42 cases of disseminated candidiasis, 71% (17) of 24 cases of zygomycosis, and 82% (9) of 11 cases of fusariosis. Response rates varied according to the pattern of invasive fungal infection, underlying condition, and reason for enrollment (intolerance versus progressive infection). These findings support the use of ABLC in the treatment of invasive fungal infections in patients who are intolerant of or refractory to conventional antifungal therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,009
Therapeutic Outcome in Invasive Aspergillosis
Denning, D. W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.608 · Cited by 689
Boutati, E. I., & Anaissie, E. J. (1997) · Blood · doi:10.1182/blood.v90.3.999 · Cited by 587
Self-citationNIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis
Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P., Kauffman, C. A., Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Sugar, A. M., Catanzaro, A., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90023-x · Cited by 450
Self-citationLipid Formulations of Amphotericin B: Recent Progress and Future Directions
Hiemenz, J. W., & Walsh, T. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s133 · Cited by 404
Self-citationRisk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369
Vascular Catheter-Associated Fungemia in Patients with Cancer: Analysis of 155 Episodes
Lecciones, J. A., Lee, J. W., Navarro, E. E., Witebsky, F. G., Marshall, D., Steinberg, S. M., Pizzo, P. A., & Walsh, T. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.4.875 · Cited by 324
Self-citationSabra, R., & Branch, R. A. (1990) · Drug Safety · doi:10.2165/00002018-199005020-00003 · Cited by 228
Unusual lipid structures selectively reduce the toxicity of amphotericin B.
Janoff, A. S., Boni, L. T., Popescu, M. C., Minchey, S. R., Cullis, P. R., Madden, T. D., Taraschi, T., Gruner, S. M., Shyamsunder, E., & Tate, M. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6122 · Cited by 223
Sharkey, P. K., Graybill, J. R., Johnson, E. S., Hausrath, S. G., Pollard, R. B., Kolokathis, A., Mildvan, D., Fan-Havard, P., Eng, R. H. K., Patterson, T. F., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.315 · Cited by 197
Self-citationLiposomal amphotericin B is toxic to fungal cells but not to mammalian cells
Mehta, R., Lopez-Berestein, G., Hopfer, R., Mills, K., & Juliano, R. L. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90135-4 · Cited by 192
Amphotericin B lipid complex therapy of experimental fungal infections in mice
Clark, J. M., Whitney, R. R., Olsen, S. J., George, R. J., Swerdel, M. R., Kunselman, L., & Bonner, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.4.615 · Cited by 159
Hepatic Mucormycosis in a Bone Marrow Transplant Recipient Who Ingested Naturopathic Medicine
Oliver, M. R., A, W. C. V. V., Boeckh, M., Mattson, D., & Bowden, R. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.521 · Cited by 156
Developments in hyalohyphomycosis and phaeohyphomycosis
Matsumoto, T., Ajello, L., Matsuda, T., Szaniszlo, P. J., & Walsh, T. J. (1994) · Medical Mycology · doi:10.1080/02681219480000951 · Cited by 147
Self-citationMILLER, R. P., & BATES, J. H. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-6-1089 · Cited by 145
Walsh, T. J., Peter, J., McGough, D. A., Fothergill, A. W., Rinaldi, M. G., & Pizzo, P. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1361 · Cited by 138
Self-citationGonzalez, C. E., Couriel, D. R., & Walsh, T. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.192 · Cited by 134
Self-citationJanoff, A. S., Perkins, W. R., Saletan, S., & Swenson, C. E. (1993) · Journal of Liposome Research · doi:10.3109/08982109309150730 · Cited by 122
Pannuti, C. M., Gingrich, R., Pfaller, M. A., kao, C., & Wenzel, R. P. (1992) · Cancer · doi:10.1002/1097-0142(19920601)69:11<2653::aid-cncr2820691106>3.0.co;2-8 · Cited by 116
A Review of Complications of Amphotericin-B Therapy: Recommendations for Prevention and Management
Maddux, M. S., & Barriere, S. L. (1980) · Annals of Pharmacotherapy · doi:10.1177/106002808001400303 · Cited by 113
The Future of Antifungal Therapy
Graybill, J. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s166 · Cited by 107
Roilides, E., Holmes, A. H., Blake, C., Pizzo, P. A., & Walsh, T. J. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.905 · Cited by 95
Self-citationAmphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity
Perkins, W. R., Minchey, S. R., Boni, L. T., Swenson, C. E., Popescu, M. C., Pasternack, R. F., & Janoff, A. S. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90414-h · Cited by 87
Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B
Wasan, K. M., Rosenblum, M. G., Cheung, L. H., & Lopez‐Berestein, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.223 · Cited by 84
LISTER, J. W. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb01348.x · Cited by 81
Self-citationTissue Distribution of Amphotericin B Lipid Complex in Laboratory Animals
Olsen, S., Swerdel, M. R., Blue, B., Clark, J. M., & BONNER, D. P. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03189.x · Cited by 79
Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia
Muñoz, F. M., Demmler, G. J., Travis, W., Ogden, A. K., Rossmann, S. N., & Rinaldi, M. G. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.2.499-503.1997 · Cited by 76
Wingard, J. R. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700664 · Cited by 72
Sarosi, G. A. (1990) · Postgraduate Medicine · doi:10.1080/00325481.1990.11716368 · Cited by 71
Roilides, E., Holmes, A., Blake, C., Pizzo, P. A., & Walsh, T. J. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.6.1562 · Cited by 67
Self-citationDenning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P. G., Kauffman, C. A., Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Sugar, A. M., Catanzaro, A., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90341-7 · Cited by 66
Self-citationFungal infections in iatrogenically compromised hosts.
Rex, J. H., Tj, W., & Ej, A. (1998) · PubMed · Cited by 54
Perfect, J. R., & Wright, K. A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.1.73 · Cited by 52
Self-citationLimited Toxicity of Prolonged Therapy with High Doses of Amphotericin B Lipid Complex
Kline, S., Larsen, T., Fieber, L. A., Fishbach, R., Greenwood, M. F., Harris, R. C., Kline, M. W., Tennican, P. O., & Janoff, E. N. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1154 · Cited by 37
Mitsutake, K., Kohno, S., Miyazaki, Y., et al. (1994) · Mycopathologia · doi:10.1007/bf01104273 · Cited by 23
Allendoerfer, R., Yates, R. R., Sun, S. H., & Graybill, J. R. (1992) · Medical Mycology · doi:10.1080/02681219280000491 · Cited by 17
Cited by
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citation
Metadata
- Authors
- Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., Lister, J., & Anaissie, E. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-06
- Volume
- 26
- Issue
- 6
- Pages
- 1383-1396
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2144030592
- Cited by
- 629
- References
- 36
- FWCI
- 27.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.